Octagos Health Secures $43M in Series B Funding to Advance AI-Driven Cardiac Care

Read Time:1 Minute, 42 Second

Key Highlights of the Series B Funding Round

Total Investment: Over $43 million raised in Series B funding.
Lead Investor: Morgan Stanley Expansion Capital.
Continued Support: Mucker Capital and other strategic investors.
Funding Purpose: Accelerate growth, expand into new cardiac care areas, and enhance AI-driven solutions.

About Octagos Health

Platform Overview: Octagos Health offers an AI-driven platform for continuous monitoring and data analysis of patients with cardiac devices including pacemakers, defibrillators, ambulatory monitors, and consumer wearables.
Proprietary Technology: Atlas AI delivers high accuracy in detecting clinically relevant events, automating workflows, and supporting informed decision-making in cardiology practices.
Integration and Reporting: Features seamless EHR integration and customizable reporting capabilities.

CEO and COO Insights

Dr. Shanti Bansal, CEO of Octagos Health: “The Series B funding will accelerate our growth across the US and help expand into new areas of cardiac care. We are thrilled to have Morgan Stanley Expansion Capital as our lead investor and Mucker Capital’s continued support. Our goal is to build a comprehensive AI-based clinical decision support engine for healthcare.”
Eric Olsen, COO of Octagos Health: “This investment will enable us to enhance our platform, scale our commercial team, and improve our integration with EHR systems. We are the only company offering a solution for migrating historical data from legacy systems and providing customized reporting and analytics.”

Investor Perspectives

Melissa Daniels, Managing Director of Morgan Stanley Expansion Capital: “We are excited to support Octagos Health’s vision for transforming cardiac care. Their innovative platform and vertically integrated approach significantly improve patient care and streamline monitoring processes.”
Will Hsu, Co-Founder and Partner at Mucker Capital: “Octagos Health is set for scale with industry-leading margins and a product that clinicians love. This funding will support their expansion into new diagnostic and consumer devices.”

Future Outlook

With this new round of funding, Octagos Health plans to continue its mission of advancing cardiac care through AI-driven solutions. The company aims to enhance its platform’s capabilities and expand its reach in the cardiac care sector.